Stem is a developer of a cloud-based energy solution. The Company has developed a system which leverages real-time data, cloud-based predictive analytics, energy storage, and value-added services to help businesses optimize their energy use, and for utilities to help stabilize the grid.

Millbrae, US
Size (employees)
166 (est)
Stem was founded in 2009 and is headquartered in Millbrae, US
Report incorrect company information

Key People/Management at Stem

John Carrington

John Carrington

CEO and Director
Bill Bush

Bill Bush

Chief Financial Officer
Larsh Johnson

Larsh Johnson

Chief Technology Officer
David Erhart

David Erhart

VP of Engineering
Randy Palombi

Randy Palombi

VP of Sales
Prakesh Patel

Prakesh Patel

VP of Capital Markets & Strategy
Show more

Stem Office Locations

Stem has an office in Millbrae
Millbrae, US (HQ)
100 Rollins Road
Show all (1)
Report incorrect company information

Stem Financials and Metrics

Summary Metrics

Stem's latest funding round in January 2018 was reported to be $80 m. In total, Stem has raised $295.1 m

Stem Operating Metrics

Stem's Patent Applications was reported to be 5 in Feb, 2018.
Feb, 2018

Patent Applications

Show all operating metrics
Report incorrect company information

Stem News and Updates

Global Stem Cell Banking Market 2018 Share, Trend, Segmentation And Forecast To 2023

Stem Cell Banking -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Automated Cell Culture Market 2018 Highlights | By Application - Drug Development, Stem Cell Research, Cancer Research | Terrific Growth of 8.5% with Leading Players by 2023

Automated Cell Culture Market: By Type (Finite and Infinite Cell Line Cultures), By Consumables (Media, Sera And Reagents), And By End User (Biotech Companies, Research Organizations, Academic Institutes) - Global Forecast Till 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Bioreactor Market By Type (Stirred Tank Bioreactor, Airlift Bioreactor, Packed Bed Bioreactor, Fluidized Bed Bioreactor, Photo Bioreactor, Others); By Application (Stem Cells, T Cells, Mammalian Cell

The Global Bioreactor Market, in terms of revenue, which was esteemed at US$ 565.64 million in 2015, is relied upon to achieve an estimation of US$ 787.57 million by 2021, developing at a CAGR of 6.9% throughout the forecast time frame. Posted via Industry Today. Follow us on Twitter @IndustryToday

Animal Stem Cell Therapy Market Prophesied to Grow at a Faster Pace by 2025

Increasing prevalence of disease in animals with growing population and to increase the animal’s quality of life, the companies focus shifting towards animal stem cell therapies. Posted via Industry Today. Follow us on Twitter @IndustryToday

Graft Versus Host Disease GvHD Treatment Market to be at Forefront by 2026

Future Market Insights has announced the addition of the “Graft Versus Host Disease GvHD Treatment Market: Global Industry Analysis and Opportunity Assessment, 2016-2026"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information